Analysis demonstrates improved risk assessment for radiation pneumonitis in lung cancer patients with interstitial lung disease, suggesting personalized treatment adjustments.
The integrated nomogram combining clinical, dosimetric, and inflammatory predictors enables accurate, individualized RP risk assessment in lung cancer patients with ILD. It can guide adjustments to individualized radiotherapy plans or preventive interventions, supporting better patient selection, treatment decisions, and proactive follow-up.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: